Salesforce also offers professional services and in-person and online courses to certify its customers and partners on architecting, administering, deploying and developing its service offerings. The company provides its services through direct sales and consulting firms, systems integrators and other partners.
Goldman Sachs has set its price objective at $300, which towers over the $190.91 consensus target. Monday’s close was at $169.05. Salesforce stock hitting the Goldman Sachs target would be an incredible 75% gain.
Seagen
While somewhat more off the radar, this biotechnology stock may prove to be a huge winner this year. Seagen Inc. (NASDAQ: SGEN) develops and commercializes therapies for the treatment of cancer in the United States and internationally.
The company’s offerings include the following:
- Adcetris, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas
- Padcev, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothelial cancer
- Tukysa, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer
- Tivdak for metastatic cervical cancer and other solid tumors
- Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors
- Disitamab Vedotin, a novel HER2-targeted ADC
It also offers SEA-CD40, SEA-TGT, SEA-BCMA and SEA-CD70 for various cancer diseases.
Seagen has collaboration agreements with Agensys, Genmab, Merck, RemeGen and Takeda Pharmaceutical.
Seagen stock has a $213 price target at Goldman Sachs. The consensus target is just $162.57. From Monday’s close at $136.00, the upside to the firm’s target would be 55%.
Five outstanding companies that are the top picks at Goldman Sachs that all have a dominant position in their respective silos, and all have some huge upside to the target prices. Given that more of the same trouble we have seen this year could be coming our way in the first half of 2023 in the form of interest rates increases, inflation and market volatility, it makes sense to scale into positions slowly.
Originally published at 24/7 Wall St.
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
